Tag Archives: generic drugs

Recap of the DIA Annual Meeting 2011

Posted on 14 July 2011 by Ask-Cato.com Contributor

The 47th Annual DIA Meeting was held on 19-23 June 2011 in Chicago and was a great success with thousands of attendees from the health care industry and regulators from around the world including representatives from the FDA, the EMA, … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Generic Lovenox – Moving One Step Closer to Biosimilars

Posted on 27 July 2010 by Leo DiNapoli

We bleed from similar veins. – Tupac Shakur Lovenox is not, I repeat, not a biologic therapeutic.  It is derived from a biological source (pig intestines, yum), but it is not protein-based.  However, the FDA’s approval of a generic form … Continue reading →

Posted in FDA, Industry News | Tagged , , , , | 1 Comment

Drug/Biologic/Device Highlights from the Health Care Reform Bill

Posted on 19 April 2010 by Leo DiNapoli

Cautious, careful people, always casting about to preserve their reputations… can never effect a reform. – Susan B. Anthony Last month, the company behind the FDA Law Blog, Hyman, Phelps & McNamara, P.C., prepared a memo that outlines the provisions … Continue reading →

Posted in FDA, Industry News | Tagged , , , , , , , , , , , , , , | 1 Comment